tiprankstipranks
Teladoc Inc. (TDOC)
NYSE:TDOC
US Market
TDOC
Teladoc
RESEARCH TOOLSreports
Want to see TDOC full AI Analyst Report?

Teladoc (TDOC) Stock Forecast & Price Target

12,092 Followers
See the Price Targets and Ratings of:

TDOC Analyst Ratings

Moderate Buy
22Ratings
Moderate Buy
7 Buy
15 Hold
0 Sell
Based on 22 analysts giving stock ratings to
Teladoc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TDOC Stock 12 Month Forecast

Average Price Target

$7.22
▲(26.87% Upside)
Based on 22 Wall Street analysts offering 12 month price targets for Teladoc in the last 3 months. The average price target is $7.22 with a high forecast of $11.00 and a low forecast of $5.00. The average price target represents a 26.87% change from the last price of $5.69.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","6":"$6","8":"$8","10":"$10","12":"$12"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$11.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.21875,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$7.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,6,8,10,12],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.46,6.809230769230769,7.158461538461538,7.507692307692308,7.856923076923077,8.206153846153846,8.555384615384614,8.904615384615385,9.253846153846155,9.603076923076923,9.952307692307691,10.301538461538462,10.650769230769232,{"y":11,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.46,6.518365384615384,6.576730769230769,6.6350961538461535,6.693461538461539,6.751826923076923,6.810192307692308,6.868557692307692,6.926923076923077,6.985288461538461,7.0436538461538465,7.102019230769231,7.160384615384615,{"y":7.21875,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.46,6.3476923076923075,6.235384615384615,6.123076923076923,6.010769230769231,5.898461538461539,5.786153846153846,5.673846153846154,5.561538461538461,5.44923076923077,5.336923076923076,5.224615384615385,5.112307692307692,{"y":5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.99,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.87,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.58,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.94,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.64,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.63,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.44,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.37,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.16,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.28,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.46,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$11.00Average Price Target$7.22Lowest Price Target$5.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on TDOC
Kevin Caliendo
UBS
UBS
$6
Hold
5.45%
Upside
Reiterated
05/15/26
Teladoc (TDOC) Gets a Hold from UBS
Citi Analyst forecast on TDOC
Daniel Grosslight
Citi
Citi
$6→$7
Hold
23.02%
Upside
Assigned
05/05/26
Teladoc price target raised to $7 from $6 at CitiTeladoc price target raised to $7 from $6 at Citi
Barclays Analyst forecast on TDOC
Peter Warendorf
Barclays
Barclays
$7
Hold
23.02%
Upside
Reiterated
05/05/26
Barclays Sticks to Its Hold Rating for Teladoc (TDOC)
TD Cowen Analyst forecast on TDOC
Charles Rhyee
TD Cowen
TD Cowen
$6
Hold
5.45%
Upside
Assigned
05/04/26
Teladoc Hold Rating Reaffirmed as 2026 Outlook Tightens and $6 DCF-Based Price Target Remains Unchanged
Bank of America Securities Analyst forecast on TDOC
Allen Lutz
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
04/30/26
Analysts' Top Healthcare Picks: Ionis Pharmaceuticals (IONS), Teladoc (TDOC)
Canaccord Genuity Analyst forecast on TDOC
Richard Close
Canaccord Genuity
Canaccord Genuity
$10
Buy
75.75%
Upside
Reiterated
04/30/26
Analysts Are Bullish on These Healthcare Stocks: Teladoc (TDOC), Pfizer (PFE)
Stifel Nicolaus Analyst forecast on TDOC
David Grossman
Stifel Nicolaus
Stifel Nicolaus
$6→$5.5
Hold
-3.34%
Downside
Reiterated
04/30/26
Teladoc price target lowered to $5.50 from $6 at StifelTeladoc price target lowered to $5.50 from $6 at Stifel
Evercore ISI Analyst forecast on TDOC
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$6
Hold
5.45%
Upside
Reiterated
04/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (NYSE: TDOC), Bausch Health Companies (NYSE: BHC) and AbbVie (NYSE: ABBV)
Wells Fargo Analyst forecast on TDOC
Stan Berenshteyn
Wells Fargo
Wells Fargo
$6
Hold
5.45%
Upside
Reiterated
04/30/26
Wells Fargo Sticks to Its Hold Rating for Teladoc (TDOC)
BTIG Analyst forecast on TDOC
David Larsen
BTIG
BTIG
―
Hold
―
Reiterated
04/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Opus Genetics (NASDAQ: IRD), NeoGenomics (NASDAQ: NEO) and Teladoc (NYSE: TDOC)
Truist Financial Analyst forecast on TDOC
Jailendra Singh
Truist Financial
Truist Financial
―
Hold
―
Reiterated
04/30/26
Analysts Are Neutral on These Healthcare Stocks: Teladoc (TDOC), Biogen (BIIB)
Needham Analyst forecast on TDOC
Ryan MacDonald
Needham
Needham
―
Hold
―
Reiterated
04/30/26
Analysts Conflicted on These Healthcare Names: Teladoc (NYSE: TDOC), Madrigal Pharmaceuticals (NASDAQ: MDGL) and Pulmonx (NASDAQ: LUNG)
Cantor Fitzgerald Analyst forecast on TDOC
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$10
Buy
75.75%
Upside
Reiterated
04/29/26
Cantor Fitzgerald Remains a Buy on Teladoc (TDOC)
William Blair Analyst forecast on TDOC
Ryan Daniels
William Blair
William Blair
―
Hold
―
Reiterated
04/29/26
Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC) and Alector (NASDAQ: ALEC)
BMO Capital Analyst forecast on TDOC
Sean Dodge
BMO Capital
BMO Capital
$5
Hold
-12.13%
Downside
Reiterated
04/29/26
Analysts Conflicted on These Healthcare Names: Teladoc (NYSE: TDOC), Spyre Therapeutics (NASDAQ: SYRE) and Regeneron (NASDAQ: REGN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on TDOC
Kevin Caliendo
UBS
UBS
$6
Hold
5.45%
Upside
Reiterated
05/15/26
Teladoc (TDOC) Gets a Hold from UBS
Citi Analyst forecast on TDOC
Daniel Grosslight
Citi
Citi
$6→$7
Hold
23.02%
Upside
Assigned
05/05/26
Teladoc price target raised to $7 from $6 at CitiTeladoc price target raised to $7 from $6 at Citi
Barclays Analyst forecast on TDOC
Peter Warendorf
Barclays
Barclays
$7
Hold
23.02%
Upside
Reiterated
05/05/26
Barclays Sticks to Its Hold Rating for Teladoc (TDOC)
TD Cowen Analyst forecast on TDOC
Charles Rhyee
TD Cowen
TD Cowen
$6
Hold
5.45%
Upside
Assigned
05/04/26
Teladoc Hold Rating Reaffirmed as 2026 Outlook Tightens and $6 DCF-Based Price Target Remains Unchanged
Bank of America Securities Analyst forecast on TDOC
Allen Lutz
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
04/30/26
Analysts' Top Healthcare Picks: Ionis Pharmaceuticals (IONS), Teladoc (TDOC)
Canaccord Genuity Analyst forecast on TDOC
Richard Close
Canaccord Genuity
Canaccord Genuity
$10
Buy
75.75%
Upside
Reiterated
04/30/26
Analysts Are Bullish on These Healthcare Stocks: Teladoc (TDOC), Pfizer (PFE)
Stifel Nicolaus Analyst forecast on TDOC
David Grossman
Stifel Nicolaus
Stifel Nicolaus
$6→$5.5
Hold
-3.34%
Downside
Reiterated
04/30/26
Teladoc price target lowered to $5.50 from $6 at StifelTeladoc price target lowered to $5.50 from $6 at Stifel
Evercore ISI Analyst forecast on TDOC
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$6
Hold
5.45%
Upside
Reiterated
04/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (NYSE: TDOC), Bausch Health Companies (NYSE: BHC) and AbbVie (NYSE: ABBV)
Wells Fargo Analyst forecast on TDOC
Stan Berenshteyn
Wells Fargo
Wells Fargo
$6
Hold
5.45%
Upside
Reiterated
04/30/26
Wells Fargo Sticks to Its Hold Rating for Teladoc (TDOC)
BTIG Analyst forecast on TDOC
David Larsen
BTIG
BTIG
―
Hold
―
Reiterated
04/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Opus Genetics (NASDAQ: IRD), NeoGenomics (NASDAQ: NEO) and Teladoc (NYSE: TDOC)
Truist Financial Analyst forecast on TDOC
Jailendra Singh
Truist Financial
Truist Financial
―
Hold
―
Reiterated
04/30/26
Analysts Are Neutral on These Healthcare Stocks: Teladoc (TDOC), Biogen (BIIB)
Needham Analyst forecast on TDOC
Ryan MacDonald
Needham
Needham
―
Hold
―
Reiterated
04/30/26
Analysts Conflicted on These Healthcare Names: Teladoc (NYSE: TDOC), Madrigal Pharmaceuticals (NASDAQ: MDGL) and Pulmonx (NASDAQ: LUNG)
Cantor Fitzgerald Analyst forecast on TDOC
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$10
Buy
75.75%
Upside
Reiterated
04/29/26
Cantor Fitzgerald Remains a Buy on Teladoc (TDOC)
William Blair Analyst forecast on TDOC
Ryan Daniels
William Blair
William Blair
―
Hold
―
Reiterated
04/29/26
Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC) and Alector (NASDAQ: ALEC)
BMO Capital Analyst forecast on TDOC
Sean Dodge
BMO Capital
BMO Capital
$5
Hold
-12.13%
Downside
Reiterated
04/29/26
Analysts Conflicted on These Healthcare Names: Teladoc (NYSE: TDOC), Spyre Therapeutics (NASDAQ: SYRE) and Regeneron (NASDAQ: REGN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Teladoc

3 Months
xxx
Success Rate
26/48 ratings generated profit
54%
Average Return
+1.13%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 54.17% of your transactions generating a profit, with an average return of +1.13% per trade.
1 Year
George HillDeutsche Bank
Success Rate
10/21 ratings generated profit
48%
Average Return
+15.57%
Copying George Hill's trades and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of +15.57% per trade.
2 Years
xxx
Success Rate
11/21 ratings generated profit
52%
Average Return
+37.41%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 52.38% of your transactions generating a profit, with an average return of +37.41% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TDOC Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
3
4
6
3
Buy
2
4
7
6
4
Hold
16
24
29
33
23
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
31
40
45
30
In the current month, TDOC has received 7 Buy Ratings, 23 Hold Ratings, and 0 Sell Ratings. TDOC average Analyst price target in the past 3 months is 7.22.
Each month's total comprises the sum of three months' worth of ratings.

TDOC Financial Forecast

TDOC Earnings Forecast

Next quarter’s earnings estimate for TDOC is -$0.25 with a range of -$0.29 to -$0.22. The previous quarter’s EPS was -$0.36. TDOC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year TDOC has Performed in-line its overall industry.
Next quarter’s earnings estimate for TDOC is -$0.25 with a range of -$0.29 to -$0.22. The previous quarter’s EPS was -$0.36. TDOC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year TDOC has Performed in-line its overall industry.

TDOC Sales Forecast

Next quarter’s sales forecast for TDOC is $615.02M with a range of $611.00M to $623.93M. The previous quarter’s sales results were $613.85M. TDOC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year TDOC has Performed in-line its overall industry.
Next quarter’s sales forecast for TDOC is $615.02M with a range of $611.00M to $623.93M. The previous quarter’s sales results were $613.85M. TDOC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year TDOC has Performed in-line its overall industry.

TDOC Stock Forecast FAQ

What is TDOC’s average 12-month price target, according to analysts?
Based on analyst ratings, Teladoc Inc.’s 12-month average price target is 7.22.
    What is TDOC’s upside potential, based on the analysts’ average price target?
    Teladoc Inc. has 26.87% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TDOC a Buy, Sell or Hold?
          Teladoc Inc. has a consensus rating of Moderate Buy which is based on 7 buy ratings, 15 hold ratings and 0 sell ratings.
            What is Teladoc Inc.’s price target?
            The average price target for Teladoc Inc. is 7.22. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $11.00 ,the lowest forecast is $5.00. The average price target represents 26.87% Increase from the current price of $5.69.
              What do analysts say about Teladoc Inc.?
              Teladoc Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.
                How can I buy shares of TDOC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.